Table 3 Asthma symptoms and indicators of exacerbations by accurately versus inaccurately reported ‘well-controlled’ asthma.

From: A multinational observational study identifying primary care patients at risk of overestimation of asthma control

 

Patient reported ‘well-controlled’ asthma (N = 2582)

p Value*

 

Group A

Group B

 
 

Accurately reported (n = 745)

Inaccurately reported (n = 1837)

 

Asthma symptoms (past 7 days)

Daytime symptoms, n (%)

 None

610 (81.9)

709 (38.6)

<0.001a

 1–2 days

135 (18.1)

500 (27.2)

 ≥ 3 days

0

628 (34.2)

Activity limitations due to asthma, n (%)

 None

745 (100.0)

1371 (74.6)

<0.001a

 ≥1 day

0

466 (25.4)

Night waking, n (%)

 None

745 (100.0)

1311 (71.4)

<0.001a

 ≥1 night

0

526 (28.6)

Reliever needed for symptoms, n (%)

 Not used

607 (81.5)

713 (38.8)

<0.001a

 1–2 times

136 (18.2)

355 (18.3)

 ≥3 times

2 (0.3)

769 (41.9)

Highest number of puffs of reliever inhaler taken in 1 dayb, n (%)

 0–4

736 (98.8)

1596 (86.9)

<0.001a

 5–12 or more

9 (1.2)

241 (13.1)

Acute exacerbations (past 12 months)

Oral corticosteroid use for worsening asthma, n (%)

 None

610 (81.9)

1384 (75.4)

<0.001a

 1

98 (13.2)

263 (14.3)

 ≥2

37 (5.0)

188 (10.3)

Emergency department visit due to asthma, n (%)

 None

694 (93.2)

1680 (91.5)

0.39a

 1

37 (5.0)

111 (6.0)

 ≥2

14 (1.8)

46 (2.5)

Hospitalisation due to asthma, n (%)

 None

730 (98.0)

1751 (95.4)

0.010a

 1

14 (1.9)

64 (3.5)

 ≥2

1 (0.1)

21 (1.1)

  1. *p Value of Group A versus Group B
  2. aPearson’s χ2 test for independence
  3. bHighest number of puffs of reliever inhaler use, in response to the question: ‘In the past 4 weeks, what was the highest number of puffs in 1 day you took of the reliever inhaler?’ with response options 0, 1–4 puffs and 5+ puffs